2019 Fiscal Year Research-status Report
Combination therapies for chondrosarcoma
Project/Area Number |
19K07765
|
Research Institution | Okinawa Institute of Science and Technology Graduate University |
Principal Investigator |
Guillaume Vares 沖縄科学技術大学院大学, 最先端医療機器開発ユニット, 研究員 (10415432)
|
Project Period (FY) |
2019-04-01 – 2022-03-31
|
Keywords | chondrosarcoma / cancer stem cells / particle therapy / PARP inhibitors / microRNA |
Outline of Annual Research Achievements |
We performed two series of carbon-ion irradiations at HIMAC in July and December 2019. Chondrosarcoma cells were treated with Olaparib, Velaparib and/or a mimic for miR-145. RNA and protein samples were collected and flow cytometry experiments were performed. RNA-Seq analysis was performed in January 2020. Preliminary experiments in lower oxygen concentration (physioxia) were also performed. A first manuscript was submitted for publication and is under revision.
|
Current Status of Research Progress |
Current Status of Research Progress
2: Research has progressed on the whole more than it was originally planned.
Reason
Initial experiments were performed smoothly in FY2019, however due to COVID-19, irradiation at HIMAC is stopped until further notice.
|
Strategy for Future Research Activity |
We will put the plan temporarily on hold in FY2020 because I am leaving OIST.
|